This study investigates the detection of aero-digestive tract cancer using rectal mucus. The purpose is to explore the possibility of identifying non-colorectal cancers through genomic and epigenetic analysis of rectal mucus samples.
The study evaluates the effectiveness of rectal mucus sampling in detecting DNA mutations and methylation changes associated with aero-digestive tract cancers. This study evaluates the potential of this method as a less invasive screening tool.
- Who can participate: Adults aged 18 years or older who can provide written informed consent are eligible. Exclusions include those with conditions making rectal exams inappropriate, a history of cancer, or prior cancer treatments. The criteria are fully aligned with the eligibility requirements.
- Study details: Participants will provide rectal mucus samples for analysis. The study involves the use of a sampling device to collect these samples.
How understandable was the trial content above?
Hard to understand
Easy to understand